3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
55
Multiple Myeloma
53
Hodgkin Disease
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Lymphoma, Non-Hodgkin
46
Leukemia, Lymphocytic, Chronic, B-Cell
44
Myelodysplastic Syndromes
41
Lymphoma, Mantle-Cell
39
Lymphoma, Large B-Cell, Diffuse
38
Lymphoma, Follicular
36
Leukemia
36
Congenital Abnormalities
36
Burkitt Lymphoma
34
Myeloproliferative Disorders
31
Lymphoma
30
Lymphoma, B-Cell, Marginal Zone
29
Lymphoma, Large-Cell, Immunoblastic
28
Leukemia, Myeloid, Accelerated Phase
27
Leukemia, Myeloid, Chronic-Phase
26
Waldenstrom Macroglobulinemia
25
Blast Crisis
25
Leukemia, Myelomonocytic, Chronic
24
Recurrence
19
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
19
Neoplasms, Plasma Cell
18
Lymphoma, Large-Cell, Anaplastic
18
Myelodysplastic-Myeloproliferative Diseases
16
Sezary Syndrome
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Interventions
Gemcitabine
19
Cisplatin
11
Capecitabine
9
Oxaliplatin
7
Fluorouracil
5
pembrolizumab
4
Leucovorin
4
Sorafenib
3
Magnetic Resonance Spectroscopy
3
Erlotinib Hydrochloride
3
trifluridine tipiracil drug combination
2
regorafenib
2
cobimetinib
2
atezolizumab
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Platinum
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Lapatinib
2
Biopsy
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
varlilumab
1
vandetanib
1
tucatinib
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gallbladder Neoplasms
×
Peripheral Blood Stem Cell Transplantation
×
Clear all
No trials found.